May 11, 2018
SDS Rx, the leading provider of last mile logistics services to wholesale pharmaceutical distributors, pharmacies, laboratories and Healthcare Systems, has announced a strategic investment by a leading middle market private equity firm. HCI Equity Partners has made a substantial equity investment, through their Fund 5, in SDS Rx and their subsidiaries. The investment by HCI Equity Partners, enables SDS Rx to continue its aggressive service and technology platforms. Drew Kronick, CEO of SDS Rx, commented, “We have enjoyed eight consecutive years of growth, building on our service-first commitment. This new investment allows us to invest heavily in additional functional support, in our IT and information platform, and in the delivery network that supports our healthcare customers every day.
Doug McCormick, Managing Partner of HCI, commented, “we were drawn to SDS Rx by the cross- section of logistics and healthcare. Drew has built a great team, and so our investment combined with their technology platform and entrepreneurial culture, will produce the strength to accelerate a service-first solution.
About SDS Rx
Founded in 2009 as Strategic Delivery Solutions, SDS Rx has since grown to become the leading last mile provider of delivery and logistics service to the American healthcare industry. With a growing national footprint, the company credits its success to rigorous quality control standards, operational transparency, advanced technology and a tireless commitment to meeting the needs of the patients and providers who depend on its performance every day.
HCI is a private equity firm that invests in lower middle market, growth-oriented distribution, manufacturing and service companies. The firm currently manages nearly $1 billion in equity commitments and closed its latest fund (“HCI V”) at over $400 million in November 2017. With diverse operating experience and an active approach, HCI strives to be business partners rather than simply capital providers. They build solid partnerships with company owners and management teams to assist with identification and execution of organic and acquisition growth initiatives. For more information, please visit HCI’s website: www.hciequity.com.